Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dysregulation of the TOX-RUNX3 pathway in cutaneous T-cell lymphoma

5 Nov 2015

Abstract excerpt

// Brittany O. Dulmage 1 , Oleg Akilov 1 , John R. Vu 1 , Louis D. Falo 1 , Larisa J. Geskin 2 1 Department of Dermatology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA 2 Department of Dermatology, Columbia University, New York, New York, USA Correspondence to: Larisa J. Geskin, e-mail: ljg2145@columbia.edu Keywords: cutaneous T-cell lymphoma; Sézary syndrome; gene expression; romidepsin; TOX Received:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cutaneous lymphoproliferative disorders research
Share to Fungal Infections and Studies
Share to T-cell and Retrovirus Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31139323
DOI: 10.18632/oncotarget.5742

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dysregulation of the TOX-RUNX3 pathway in cutaneous T-cell lymphomaPMID 31139323Read ↗

Sézary syndrome: old enigmas, new targets.Semantic proximity Read ↗

Evidence of an oncogenic role of aberrant TOX activation in cutaneous T-cell lymphomaSemantic proximity Read ↗

Single-cell analysis of Sézary syndrome reveals novel markers and shifting gene profiles associated with treatmentSemantic proximity Read ↗

Sézary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3Semantic proximity Read ↗

Phenotypic plasticity of malignant T cells in blood and skin of a Sézary syndrome patient revealed by single cell transcriptomicsSemantic proximity Read ↗

Single-Cell Profiling Reveals Targetable Malignant T-Cell Subtypes and Immune Evasion Pathways in Sézary SyndromeSemantic proximity Read ↗

Genetic rearrangements result in altered gene expression and novel fusion transcripts in Sézary syndromeSemantic proximity Read ↗

Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes.Semantic proximity Read ↗

Transcriptome sequencing in Sézary syndrome identifies Sézary cell and mycosis fungoides-associated lncRNAs and novel transcriptsSemantic proximity Read ↗

New Insights Into the Complex Mutational Landscape of Sézary SyndromeSemantic proximity Read ↗

The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome.Semantic proximity Read ↗

Molecular pathogenesis of cutaneous lymphoma-Future directions.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.